Patients treated with a CRT-D in the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region ( STARTER ) prospective , randomized trial ( @ EG strategy and @ routine strategy ) were followed to the endpoint of death or first appropriate CRT-D therapy .